Testing a scan tracer called FET to find brain tumors
Original title: Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
The study does not say what stage of testing it is in.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a substance called FET to help spot brain tumors on scans.
Who this trial is for. This study is for people with a brain tumor in the brain or skull. It is testing a substance called FET, which builds up in cancer cells. The team wants to see if it can find a tumor that has come back, and help show the grade of a glial tumor. The study runs at one center.
Where it stands. This trial has not reported results. It is looking at how well FET shows brain tumors. The answer is not in yet.
What this means, and what it doesn't
What it could mean: If this works, doctors may one day have another way to look at brain tumors on scans. For now it is still being tested. Someone who fits could ask their care team about it.
What it doesn't mean: This does not mean FET is a proven test you can get today. A trial is a test, not proven care. Being in a trial is not a promise that it will help you. It is not a cure, and it is not a treatment.
Source: ClinicalTrials.gov, August 27, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.